EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC 3.0

Efficacy and Safety of Dexmedetomidine Nasal Spray as a Premedication in Patients Undergoing Fiberoptic Bronchoscopy Under Sedation: A Randomized Controlled Trial

Guilin Zhao, Weiyong Qin, Jiangdong Wu, Shenqiao Wei, Xiaoqing Jiang, Hang Qiu, Xueke Du iD, Lini Chen

Drug Design, Development and Therapy · 2025

DOI: 10.2147/dddt.s550551 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Drug Design, Development and Therapy, 2025. Verfasst von Guilin Zhao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, The Second Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, 530007, People's Republic of China. Hauptthemen laut MEDLINE: Bronchoscopy, Dexmedetomidine, Hypnotics and Sedatives, Premedication. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Fiberoptic bronchoscopy (FB) under sedation can provoke patient discomfort, cough, and hemodynamic fluctuations. This study evaluated the efficacy and safety of dexmedetomidine nasal spray as a premedication compared to intranasal normal saline and lidocaine.

Methods

A total of 90 patients scheduled for FB under sedation were randomly assigned to three groups. Group D (dexmedetomidine), Group C (control, normal saline), and Group L (lidocaine) received pre-induction nasal sprays via the same metered-dose aerosolization device. At 10 min post-spray, all patients received standard monitored anesthesia care (MAC) with preserved spontaneous ventilation (respiratory rate, RR ≥10 breaths/min; peripheral oxygen saturation, SpO2 ≥95%). Outcomes included hemodynamic parameters (heart rate, HR; mean arterial pressure, MAP) measured at specific time points (T1-T8), Modified Observer's Assessment of Alertness/Sedation (MOAA/S) scores, cough severity and adverse events.

Results

Group D demonstrated better overall performance. Hemodynamically, HR in Group D was lower than Group C at T3 and T5, and lower than Group L at T5. MAP in Group D was lower than both control groups from T3-T6. Recovery time in Group D was shorter than in both Group C and Group L. Group D also exhibited superior MOAA/S scores (lower at T1, but higher at T6-T8), higher bronchoscopist satisfaction, and a lower incidence of both moderate-to-severe cough and postoperative nausea and vomiting (PONV) compared to the other groups. Respiratory rates were comparable, with Group D showing a higher RR than Group C at T6.

Conclusion

Premedication with dexmedetomidine nasal spray in patients undergoing FB under sedation was associated with more effective suppression of procedure-induced cough, better hemodynamic stability, a lower incidence of PONV, and a faster recovery profile compared to both intranasal saline and lidocaine, without increasing respiratory depression. Consequently, dexmedetomidine nasal spray can effectively and safely enhance patient comfort and safety, and optimize the procedural conditions for the bronchoscopists.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BronchoscopyDexmedetomidineHypnotics and SedativesPremedicationAdultAgedFemaleHumansMaleMiddle AgedAdministration, IntranasalDouble-Blind MethodFiber Optic TechnologyNasal Sprays

Stichwörter der Autor:innen

dexmedetomidine nasal sprayfiberoptic bronchoscopylidocainenormal salinesedation

Substanzen

DexmedetomidineHypnotics and SedativesNasal Sprays

Autor:innen und Institutionen

  • Department of Anesthesiology, The Second Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, 530007, People's Republic of China.

ORCID-Profile: Xueke Du

Zitieren

APA

Zhao, G., Qin, W., Wu, J., Wei, S., Jiang, X., Qiu, H., Du, X., & Chen, L. (2025). Efficacy and Safety of Dexmedetomidine Nasal Spray as a Premedication in Patients Undergoing Fiberoptic Bronchoscopy Under Sedation: A Randomized Controlled Trial. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s550551

Vancouver

Zhao G, Qin W, Wu J, Wei S, Jiang X, Qiu H, et al. Efficacy and Safety of Dexmedetomidine Nasal Spray as a Premedication in Patients Undergoing Fiberoptic Bronchoscopy Under Sedation: A Randomized Controlled Trial. Drug Design, Development and Therapy. 2025. doi:10.2147/dddt.s550551

BibTeX
@article{Zhao2025,
  author = {Zhao, Guilin and Qin, Weiyong and Wu, Jiangdong and Wei, Shenqiao and Jiang, Xiaoqing and Qiu, Hang and Du, Xueke and Chen, Lini},
  title = {Efficacy and Safety of Dexmedetomidine Nasal Spray as a Premedication in Patients Undergoing Fiberoptic Bronchoscopy Under Sedation: A Randomized Controlled Trial},
  journal = {Drug Design, Development and Therapy},
  year = {2025},
  doi = {10.2147/dddt.s550551}
}
Kostenlos starten →